Effects of Three Kinds of Selective Cyclooxygenase-2 Inhibitors on the Growth of Hepatocellular Carcinoma

刘纯伦,唐承薇,周旭春

DOI: https://doi.org/10.3969/j.issn.1008-7125.2004.01.002

2004-01-01

Abstract:Background: Expression of cyclooxygenase (COX)-2 can be detected in the hepatocellular carcinoma (HCC). Aspirin, a non-steroidal anti-inflammatory drug, can inhibit the growth of HCC probably through the inhibition of COX-2 expression. Aims: To compare the effects of three kinds of selective COX-2 inhibitors (meloxicam, celecoxib and rofecoxib) on the growth of human liver cancer cell line SMMC-7721, and to observe the effect of rofecoxib, a highly selective COX-2 inhibitor, on the growth of HCC implanted in the liver of nude mice. Methods: The DNA synthesis of SMMC-7721 cells was determined by 3H-thymidine (3H-TdR) incorporation method. The expression of proliferating cell nuclear antigen (PCNA) was detected by immunocytochemistry. The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was used to detect cell apoptosis. Rofecoxib (30 mg/kg per day) was administered to HCC implanted nude mice for eight weeks, the volume and weight of the xenografts in situ were measured. Results: Meloxicam, celecoxib and rofecoxib could decrease the 3H-TdR incorporation significantly in a dose-dependent manner in SMMC-7721 cells. Their 50% inhibitory concentration (IC50) were 8.55×10-8 mol/L, 1.22×10-8 mol/L and 6.27×10-9 mol/L, respectively. After treated with the above three selective COX-2 inhibitors (1×10-5 mol/L) for 24 hours, the expression of PCNA in SMMC-7721 cells were decreased, and the apoptosis index was significantly increased compared with that of the controls (14.6%±2.8%, 21.6%±3.6% and 27.1%±3.5% vs. 1.0%±0.7%, P<0.01). The higher the selectivity of COX-2, the higher the apoptosis index (P<0.01). The xenografts in situ in nude mice treated with rofecoxib were significantly smaller than those of the controls, and the inhibition rates were 73.2% in volume and 78.1% in weight. Conclusions: All three kinds of selective COX-2 inhibitors can effectively inhibit the growth of SMMC-7721 cells in vitro in proportion to their selectivity. The inhibition of HCC growth in vivo by rofecoxib suggests it may be an effective drug in the treatment of HCC.